Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine
- PMID: 7100044
- PMCID: PMC2426356
- DOI: 10.1136/pgmj.58.677.175
Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine
Abstract
Four patients are described who exhibited prolonged Q-T intervals, multiple ventricular premature beats and ventricular tachycardia of the ‘torsade de pointes’ configuration whilst on treatment with prenylamine. In two of these patients, advanced atrio-ventricular block was established immediately following intravenous administration of lignocaine. The arrhythmia and the atrio-ventricular blocks were successfully controlled by ventricular pacing. The hazard of the simultaneous administration of these two drugs is stressed.
Similar articles
-
Prenylamine-induced ventricular arrhythmias and syncopal attacks with Q-T prolongation. Report of a case and comment on therapeutic use of lignocaine.Cardiology. 1980;66(4):199-203. doi: 10.1159/000170867. Cardiology. 1980. PMID: 7448836
-
Torsade de pointes due to prenylamine controlled by lignocaine.Eur Heart J. 1982 Aug;3(4):389-92. doi: 10.1093/oxfordjournals.eurheartj.a061322. Eur Heart J. 1982. PMID: 7128627 No abstract available.
-
Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing.Br Heart J. 1980 Sep;44(3):330-4. doi: 10.1136/hrt.44.3.330. Br Heart J. 1980. PMID: 7426190 Free PMC article.
-
[Incompatibility and interference of the major cardiologic drugs. Their undesirable effects].Rev Prat. 1976 Dec 21;26(59):4239-46. Rev Prat. 1976. PMID: 794985 Review. French. No abstract available.
-
Digitalis intoxication--diagnosis, management and prevention.Cardiovasc Clin. 1974;6(2):153-74. Cardiovasc Clin. 1974. PMID: 4613458 Review. No abstract available.
Cited by
-
Ventricular tachycardia precipitated by sodium iothalamate (Conray 420) injection during prenylamine treatment: a predictable adverse drug interaction.Postgrad Med J. 1985 May;61(715):415-7. doi: 10.1136/pgmj.61.715.415. Postgrad Med J. 1985. PMID: 4022877 Free PMC article.
-
QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.Cardiovasc Drugs Ther. 1991 Apr;5(2):515-30. doi: 10.1007/BF03029779. Cardiovasc Drugs Ther. 1991. PMID: 1854661 Review.
-
The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels.Front Pharmacol. 2022 May 2;13:809802. doi: 10.3389/fphar.2022.809802. eCollection 2022. Front Pharmacol. 2022. PMID: 35586063 Free PMC article.